Literature DB >> 86391

The clinical evaluation of analogues II. Bleomycins.

S K Carter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 86391     DOI： 10.1007/BF00253111

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  10 in total

1.  A clinical review of bleomycin--a new antineoplastic agent.

Authors:  R H Blum; S K Carter; K Agre
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

2.  Effects of bleomycin on pulmonary function in man.

Authors:  R S Pascual; M B Mosher; R S Sikand; R C De Conti; A Bouhuys
Journal:  Am Rev Respir Dis       Date:  1973-08

3.  Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients.

Authors:  A Yagoda; B Mukherji; C Young; E Etcubanas; C Lamonte; J R Smith; C T Tan; I H Krakoff
Journal:  Ann Intern Med       Date:  1972-12       Impact factor: 25.391

4.  Results of combination chemotherapy of non-Hodgkin's lymphoma.

Authors:  P S Schein; B A Chabner; G P Canellos; R D Young; C Berard; V T DeVita
Journal:  Br J Cancer Suppl       Date:  1975-03

Review 5.  Current status of American studies with bleomycin.

Authors:  S K Carter; R H Blum
Journal:  Prog Biochem Pharmacol       Date:  1976

Review 6.  The integration of chemotherapy into a combined modality approached to cancer therapy. V. Squamous cell cancer of the head and neck.

Authors:  M A Goldsmith; S K Carter
Journal:  Cancer Treat Rev       Date:  1975-06       Impact factor: 12.111

7.  COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors.

Authors:  R B Livingston; L H Einhorn; G P Bodey; M A Burgess; E J Freireich; J A Gottlieb
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

8.  Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.

Authors:  G Bonadonna; R Zucali; S Monfardini; M De Lena; C Uslenghi
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

9.  Large-dose bleomycin therapy and pulmonary toxicity. A possible role of prior radiotherapy.

Authors:  M L Samuels; D E Johnson; P Y Holoye; V J Lanzotti
Journal:  JAMA       Date:  1976-03-15       Impact factor: 56.272

Review 10.  The integration of chemotherapy into combined modality treatment of solid tumors. VIII. Cervical cancer.

Authors:  T H Wasserman; S K Carter
Journal:  Cancer Treat Rev       Date:  1977-03       Impact factor: 12.111
  10 in total
  1 in total

1.  Therapy of solid Walker carcinosarcoma 256 with bleomycin after synchronization with hydroxyurea.

Authors:  M Volm; J Mattern; N Weber; K Wayss
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.